TransDigm Group Incorporated (NYSE:TDG) Expected to Post Quarterly Sales of $1.40 Billion - Defense World

2022-05-29 11:17:54 By : Mr. Kaibo Yang

Posted by admin on May 23rd, 2022

Brokerages expect TransDigm Group Incorporated (NYSE:TDG – Get Rating) to report sales of $1.40 billion for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for TransDigm Group’s earnings, with estimates ranging from $1.35 billion to $1.43 billion. TransDigm Group posted sales of $1.22 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 14.8%. The firm is scheduled to issue its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that TransDigm Group will report full-year sales of $5.41 billion for the current year, with estimates ranging from $5.38 billion to $5.44 billion. For the next financial year, analysts forecast that the company will report sales of $5.98 billion, with estimates ranging from $5.80 billion to $6.24 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for TransDigm Group.

TransDigm Group (NYSE:TDG – Get Rating) last issued its quarterly earnings results on Tuesday, May 10th. The aerospace company reported $3.29 EPS for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.02). The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.31 billion. TransDigm Group had a negative return on equity of 27.39% and a net margin of 17.70%. TransDigm Group’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the firm posted $2.29 EPS.

A number of equities analysts have recently commented on TDG shares. Wells Fargo & Company cut their price target on shares of TransDigm Group from $700.00 to $620.00 in a report on Wednesday, May 11th. Susquehanna Bancshares cut their price target on shares of TransDigm Group from $720.00 to $620.00 in a report on Wednesday, May 11th. StockNews.com lowered shares of TransDigm Group from a “buy” rating to a “hold” rating in a report on Thursday. Morgan Stanley boosted their target price on shares of TransDigm Group from $762.00 to $801.00 and gave the company an “overweight” rating in a report on Wednesday, February 9th. Finally, Susquehanna dropped their target price on shares of TransDigm Group from $720.00 to $620.00 in a report on Wednesday, May 11th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $707.33.

In other news, Director Raymond F. Laubenthal sold 5,000 shares of the company’s stock in a transaction dated Tuesday, March 22nd. The shares were sold at an average price of $670.00, for a total transaction of $3,350,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director W Nicholas Howley sold 11,500 shares of the company’s stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $631.75, for a total transaction of $7,265,125.00. Following the transaction, the director now owns 21,548 shares in the company, valued at approximately $13,612,949. The disclosure for this sale can be found here. Insiders have sold 28,000 shares of company stock worth $17,890,485 in the last quarter. Company insiders own 9.13% of the company’s stock.

Large investors have recently bought and sold shares of the company. Verdence Capital Advisors LLC increased its position in shares of TransDigm Group by 25.7% during the fourth quarter. Verdence Capital Advisors LLC now owns 822 shares of the aerospace company’s stock worth $523,000 after acquiring an additional 168 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in TransDigm Group by 117.0% in the 4th quarter. Sequoia Financial Advisors LLC now owns 7,012 shares of the aerospace company’s stock worth $4,462,000 after purchasing an additional 3,780 shares in the last quarter. Victory Capital Management Inc. grew its position in TransDigm Group by 0.4% in the 4th quarter. Victory Capital Management Inc. now owns 20,072 shares of the aerospace company’s stock worth $12,771,000 after purchasing an additional 86 shares in the last quarter. National Bank of Canada FI bought a new stake in TransDigm Group in the 4th quarter worth about $131,000. Finally, Nomura Asset Management Co. Ltd. grew its position in TransDigm Group by 6.6% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 10,921 shares of the aerospace company’s stock worth $6,949,000 after purchasing an additional 676 shares in the last quarter. 99.33% of the stock is owned by institutional investors.

Shares of NYSE:TDG opened at $550.24 on Monday. The firm has a market cap of $30.52 billion, a PE ratio of 38.29, a price-to-earnings-growth ratio of 1.70 and a beta of 1.43. The firm’s fifty day moving average is $624.01 and its 200-day moving average is $627.05. TransDigm Group has a 52 week low of $531.23 and a 52 week high of $688.03.

About TransDigm Group (Get Rating)

TransDigm Group Incorporated designs, produces, and supplies aircraft components in the United States and internationally. Its Power & Control segment offers mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, databus and power controls, sensor products, switches and relay panels, hoists, winches and lifting devices, and cargo loading and handling systems.

Get a free copy of the Zacks research report on TransDigm Group (TDG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for TransDigm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransDigm Group and related companies with MarketBeat.com's FREE daily email newsletter.

$1.22 Billion in Sales Expected for Illumina, Inc. (NASDAQ:ILMN) This Quarter

bluebird bio, Inc. (NASDAQ:BLUE) Expected to Post Quarterly Sales of $8.87 Million